The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major New Product Commercialisation

4 Mar 2013 07:00

RNS Number : 0913Z
PureCircle Limited
04 March 2013
 



PURECIRCLE LIMITED

 

PureCircle Announces Plans to Commercialize High Purity Reb D

 

 

PureCircle (LSE: PURE) the world's leading producer and marketer of high purity stevia ingredients today announces it has reached a major milestone as the company prepares to commercialize its latest stevia innovation, PureCircle's high purity Reb D. Following a detailed safety evaluation by an independent Expert Panel, PureCircle's high purity Reb D has received self-affirmed GRAS status, and PureCircle has elected to formally submit its GRAS notification to the FDA for the agency's additional safety review.

 

PureCircle research has identified high purity Reb D as having one of the best sweetness profiles of any steviol glycoside from the stevia leaf. The clean sweetness of PureCircle's high purity Reb D will further enable customers to develop naturally sweetened formulations with very low to no calories, particularly in food and beverages with higher sweetness levels, such as carbonated soft drinks. Its commercialization will play an integral role in extending the company's breakthrough Stevia 3.0 innovation platform alongside other next generation innovations, such as PureCircle Alpha, SG95 and PureCircle flavor NSF-02.

 

PureCircle Reb D commercialization follows more than a decade of research and development that takes advantage of breakthroughs across the company's entire vertically integrated supply chain. The development is made possible in result of discoveries through PureCircle's Comprehensive Breeding Program involving in-house and partner (3rd party) breeding centers, its agricultural investment across Paraguay, Kenya, China and the United States and industry leading extraction and purification capabilities. In addition to proprietary high Reb D content leaf varieties, PureCircle has now secured process, method and application patents to protect this new innovation, including a suite of more than 25 patents and patent applications for the ingredient.

 

PureCircle has begun collaborating with several customers on product development, with primary focus on initial introductions in the United States. Substantial investments are focused on scaling this new technology with plans for targeted market introduction as early as the second half of 2013.

 

Commenting on the development, Magomet Malsagov, Chief Executive Officer for PureCircle said, "With PureCircle's Stevia 3.0 platform we are bringing our customers the next generation of stevia solutions. We are confident that PureCircle's Reb D introduction will be a powerful new addition to this platform and will unlock new reduced and zero calorie food and beverage solutions. Over the past two years, we have dramatically accelerated the pace of new stevia solutions to the global market. PureCircle was founded on the knowledge that the stevia leaf is a vast source of innovation and we continue to have a rich pipeline of future solutions to come."

 

 

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+603 2166 2066

William Mitchell, CFO

+44 7974 005 163

RFC Ambrian Ltd (NOMAD)

+61 8 9480 2500

Stephen Allen

 

About PureCircle

PureCircle (www.purecircle.com) is the global leader in production and marketing of high purity stevia ingredients. PureCircle leads the industry with development of a vertically integrated, sustainable and natural supply chain. Stevia is grown for PureCircle across South America, Africa, Asia and the United States where it provides a sustainable cash crop for farming communities. PureCircle has developed a broad portfolio of ingredient solutions and has pioneered such ingredients as Reb A, SG95, and breakthrough proprietary ingredient PureCircle Alpha, as well as PureCircle Flavors. PureCircle also established joint venture partnerships with sugar industry leaders to innovatively combine stevia and sugar for natural sweetening solutions and locally support customers. These global partnerships include Natural Sweet Ventures, with Imperial Sugar in the US, as well as Tereos PureCircle Solutions, with Tereos and NPSweet A/S with Nordzucker, in Europe. As part of its industry leadership, PureCircle pioneered the trust mark Stevia PureCircle®, which educates consumers about the benefits of stevia and provides a strong base of trust for both consumers and food and beverage companies alike. The company also founded The Global Stevia Institute, (globalsteviainstitute.com) the leading resource for accurate, science-based information on stevia led by a global advisory board of internationally recognized health professionals. PureCircle's global headquarters are in Kuala Lumpur, Malaysia. PureCircle shares are traded on the LSE AIM index.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSUFEDFDSEID
Date   Source Headline
1st Jul 20205:10 pmRNSScheme of Arrangement becomes Effective
30th Jun 20206:00 pmRNSNew External Auditor Appointment
29th Jun 20205:45 pmRNSChanges in the Board Composition
26th Jun 20206:37 pmRNSCourt sanction of the Scheme
18th Jun 20205:47 pmRNSResults of Court Meeting and General Meeting
18th May 20205:45 pmRNSPublication of Scheme Document
7th May 20209:37 amRNSResults of Adjourned 2019 Annual General Meeting
7th May 20207:00 amRNSDispatch Date for Scheme Document
5th May 20202:31 pmRNSPDMR Notification
1st May 20207:00 amRNSBlock Listing Application
29th Apr 20207:00 amRNSNew Banking Facility
28th Apr 20203:22 pmRNSUpdate on Adjourned 2019 Annual General Meeting
20th Apr 20209:04 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:50 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:32 amRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20203:54 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20203:08 pmRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20202:43 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:40 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:35 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:30 pmRNSForm 8.3 - PureCircle Limited
15th Apr 20207:30 amRNSRestoration PureCircle Limited
9th Apr 20204:52 pmRNSNotice of Adjourned AGM and Annual Report
9th Apr 20202:07 pmRNSOffer for PureCircle Limited
9th Apr 20201:56 pmRNSUnaudited Interim Results and Trading Update
5th Mar 20207:00 amRNSCompany Update
5th Mar 20207:00 amRNSManagement Changes
19th Feb 20207:00 amRNSUpdate on lending facilities
10th Feb 20201:25 pmRNSResults of AGM and Directorate Change
4th Feb 20202:46 pmRNSCFO appointment effective
28th Jan 20203:45 pmRNSManagement Update
14th Jan 20204:42 pmRNSNotice of AGM and Company Update
3rd Jan 20202:00 pmRNSAppointment of CFO
2nd Jan 20207:00 amRNSBlock Listing Six Monthly Return
31st Dec 201912:15 pmRNSBoard Changes
27th Dec 20192:50 pmRNSManagement and Board Committee Changes
12th Dec 20192:40 pmRNSBoard and Management Changes
22nd Nov 20193:38 pmRNSResignation of a Director
20th Nov 20197:52 amRNSCorrection: Appointment of Directors
18th Nov 20193:42 pmRNSAppointment of Directors
14th Nov 20197:40 amRNSCompany Update
12th Nov 20192:52 pmRNSResignation of Director
28th Oct 20197:48 amRNSSuspension of share listing
25th Oct 20195:23 pmRNSPostponement of results and suspension of listing
23rd Oct 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:40 pmRNSSecond Price Monitoring Extn
20th Sep 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:15 pmRNSPostponement of Results
22nd Aug 20194:35 pmRNSPrice Monitoring Extension
16th Aug 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.